Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Review Article

Cancer Stem Cells and Treatment of Cancer: An Update and Future Perspectives

In Press, (this is not the final "Version of Record"). Available online 05 October, 2023
Author(s): Mudassir Khan, Mashal Naeem, Sana Aftab Chaudary, Affan Ahmed and Aftab Ahmed*
Published on: 05 October, 2023

DOI: 10.2174/011574888X247548230921063514

Price: $95

Abstract

Cancer stem cells (CSCs) play an essential role in tumour progression and metastasis. These cells have the unique ability to self-renew and differentiate into specific tissue cell types. Their capacity for self-renewal enables CSCs to persist over time, thereby contributing to cancer relapse and therapy resistance. Therefore, targeting CSCs has emerged as a promising cancer treatment strategy. CSCs exhibit differentiation, self-renewal, and plasticity, and they contribute to multiple aspects of malignant tumours, such as recurrence, metastasis, heterogeneity, multidrug resistance, and radiation resistance. While conventional treatments predominantly target cancer cells that are not CSCs, CSCs frequently survive, resulting in tumour recurrence and relapse. This article concentrates on the development of novel therapeutic strategies that combine conventional treatments with CSC inhibitors to eradicate cancer cells and CSCs, thereby treating cancer and preventing its recurrence. However, the diversity of CSCs poses a significant obstacle to the development of CSC-targeted therapies, necessitating extensive research for a better understanding and exploration of therapeutic approaches. Future development of CSC-targeted therapies will rely heavily on overcoming this obstacle

Keywords: Cancer treatment, Cancer remision, Cancer stem cells


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy